Skip to main content

Table 1 Patient characteristics

From: Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin’s lymphoma

Parameter

All patients (%)

Patients with IR (%)

Patients with AR (%)

Total

50

28

22

Sex

 Female

18 (36)

12 (43)

6 (27)

 Male

32 (64)

16 (57)

16 (73)

Stage

 I

1 (2)

0

1 (5)

 II

26 (52)

16 (57)

10 (45)

 III

7 (14)

2 (7)

5 (23)

 IV

16 (32)

10 (36)

6 (27)

TG/TL

 1

12 (24)

6 (21)

6 (27)

 2

17 (34)

10 (36)

7 (32)

 3

21 (42)

12 (43)

9 (41)

ESR ≥ 30 mm/h

 Yes

33 (66)

19 (68)

14 (64)

 No

17 (34)

9 (32)

8 (36)

Bulk ≥ 200 ml

 Yes

17 (34)

12 (43)

5 (23)

 No

33 (66)

16 (57)

17 (77)

B-symptoms

 Yes

23 (46)

12 (43)

11 (50)

 No

27 (54)

16 (57)

11 (50)

Extranodal

 Yes

8 (16)

4 (14)

4 (18)

 No

42 (84)

24 (86)

18 (82)

Protocol

 PHL-C1

42 (84)

25 (89)

17 (77)

 PHL-C2

8 (16)

3 (11)

5 (23)

  1. IR inadequate response, AR adequate response, TG/TL treatment group/level, ESR erythrocyte sedimentation rate